Yervoy 200 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DR26F45RU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,388
Award facts
- Contract value 100% obligated
- $48,388.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on November 13, 2025, valued at $48,388.38 for the supply of Yervoy 200 mg/40 mL vials through the Defense Logistics Agency. This firm fixed-price delivery order, with completion scheduled for December 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a potential value of $999.99 million through December 2026. The award was competitively awarded with no set-aside designation. Yervoy (ipilimumab) is an immunotherapy medication used in cancer treatment, reflecting the breadth of pharmaceutical products distributed through AmerisourceBergen's federal contracts.
This delivery order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying the Defense Health Agency and other military healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, and medical devices. The company's SPE2DX contract functions as a global pharmaceutical support vehicle enabling flexible delivery of medical commodities to support military healthcare programs worldwide, with the Defense Logistics Agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions involving multiple contractors.
Quick answers
Who was awarded contract SPE2DR26F45RU?
SPE2DR26F45RU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F45RU worth?
The government has obligated $48,388 on SPE2DR26F45RU.
Is contract SPE2DR26F45RU an order under another contract?
Yes. SPE2DR26F45RU is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F45RU competed?
The extent of competition for SPE2DR26F45RU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award